1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Silk Road Medical Inc

Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke.
Erica Rogers

1213 Innsbruck Dr
Sunnyvale, California 94089-1317
Phone: 16505669060


Earnings call: Silk Road Medical reports robust Q1 growth, eyes profitability
May 01, 2024 08:58am
SILK Stock Earnings: Silk Road Medical Beats EPS, Beats Revenue for Q1 2024
May 01, 2024 00:57am

Silk Road Medical (NASDAQ: SILK ) just reported results for the first quarter of 2024. Silk Road Medical reported earnings per share of -36 cents. This was above the analyst estimate for EPS of -40 cents. The company reported revenue of $48.48 million. This was 8.51% better than the analyst estimate for revenue of $44.68 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.

Silk Road Medical GAAP EPS of -$0.36 beats by $0.04, revenue of $48.5M beats by $3.81M
Apr 30, 2024 22:09pm

Silk Road Medical surpasses expectations in Q1 2024 with higher revenue and EPS.

Source:Seeking Alpha
Silk Road Medical Reports First Quarter 2024 Financial Results
Apr 30, 2024 20:05pm

Please call me to verify details of the release at 978-460-7074